Cantor Fitzgerald’s virtual panel on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”
Virtual panel discussion
We are delighted to participate in a virtual panel discussion on “Emerging Targets in Development for Inflammatory Bowel Disease (IBD)”, which will be hosted by Cantor Fitzgerald Equity Research on April 27 at 10:00AM ET.
Invited speakers from Biomica: Dr. Elran Haber , CEO and Dr. Shiri Meshner, VP R&D.